SCND — Scientific Industries Income Statement
0.000.00%
- $15.55m
- $10.79m
- $11.11m
- 46
- 46
- 20
- 30
Annual income statement for Scientific Industries, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 June 30th | R2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.2 | 7.78 | 9.78 | 11.4 | 11.1 |
Cost of Revenue | |||||
Gross Profit | 4.37 | 3.94 | 4.98 | 5.74 | 5.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.42 | 8.45 | 14.5 | 19.1 | 20.4 |
Operating Profit | 0.776 | -0.663 | -4.71 | -7.7 | -9.26 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.77 | -0.667 | -4.05 | -7 | -9.09 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.646 | -0.453 | -3.11 | -5.65 | -9.09 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 0.646 | -0.703 | -3.67 | -5.64 | -9.09 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.646 | -0.703 | -3.67 | -5.64 | -9.09 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.427 | -0.299 | -0.975 | -0.809 | -0.896 |